Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

As a research community, we have failed to demonstrate that drugs that show substantial efficacy in animal models of cerebral ischemia can also improve outcome in human stroke. Accumulating evidence suggests that this may be due, at least in part, to problems in the design, conduct and reporting of animal experiments, which create a systematic bias resulting in the overstatement of neuroprotective efficacy. Here, we set out a series of measures to reduce bias in the design, conduct and reporting of animal experiments modeling human stroke.

Original publication

DOI

10.1111/j.1747-4949.2009.00241.x

Type

Journal article

Journal

Int J Stroke

Publication Date

02/2009

Volume

4

Pages

3 - 5

Keywords

Animals, Bias, Biomedical Research, Disease Models, Animal, Guidelines as Topic, Humans, Neuroprotective Agents, Research Design, Stroke